| scholarly article | Q13442814 |
| P50 | author | Bruce W. Robinson | Q123501547 |
| P2093 | author name string | Michael G Tovey | |
| Steve A Broomfield | |||
| Andrew J Currie | |||
| Robbert G van der Most | |||
| Amy C Prosser | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | toll-like receptor | Q408004 |
| P304 | page(s) | 1535-1544 | |
| P577 | publication date | 2008-02-01 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | Targeting the effector site with IFN-alphabeta-inducing TLR ligands reactivates tumor-resident CD8 T cell responses to eradicate established solid tumors | |
| P478 | volume | 180 |
| Q44233660 | A new era for innate immunity |
| Q39582496 | Antiproliferative and interferon-inducing activities of unique short double-stranded RNA. |
| Q27318732 | Antitumor and Antimetastatic Effect of Small Immunostimulatory RNA against B16 Melanoma in Mice |
| Q84015414 | CD8alpha+ DC are not the sole subset cross-presenting cell-associated tumor antigens from a solid tumor |
| Q37473603 | Chemoimmunotherapy: an emerging strategy for the treatment of malignant mesothelioma. |
| Q64105309 | Combined Adjuvant of Poly I:C Improves Antitumor Effects of CAR-T Cells |
| Q58599357 | Combining STING-based neoantigen-targeted vaccine with checkpoint modulators enhances antitumor immunity in murine pancreatic cancer |
| Q33502208 | Cyclophosphamide chemotherapy sensitizes tumor cells to TRAIL-dependent CD8 T cell-mediated immune attack resulting in suppression of tumor growth |
| Q39157595 | Direct effect of dsRNA mimetics on cancer cells induces endogenous IFN‐β production capable of improving dendritic cell function |
| Q37790599 | Harnessing the immune response to treat cancer |
| Q40449413 | IL-1βR-dependent priming of antitumor CD4(+) T cells and sustained antitumor immunity after peri-tumoral treatment with MSU and mycobacteria. |
| Q35711576 | Immune responses and immunotherapeutic interventions in malignant pleural mesothelioma |
| Q35179465 | Immunotherapy of hepatocellular carcinoma with small double-stranded RNA. |
| Q40789987 | In Vivo Visualizing the IFN-β Response Required for Tumor Growth Control in a Therapeutic Model of Polyadenylic-Polyuridylic Acid Administration. |
| Q43005892 | Inhibition of established subcutaneous murine tumour growth with topical Melaleuca alternifolia (tea tree) oil. |
| Q48170351 | Intratumoral delivery of tumor antigen-loaded DC and tumor-primed CD4+ T cells combined with agonist α-GITR mAb promotes durable CD8+ T-cell-dependent antitumor immunity |
| Q36863949 | Local administration of TLR ligands rescues the function of tumor-infiltrating CD8 T cells and enhances the antitumor effect of lentivector immunization |
| Q37340979 | Localized irradiation of tumors prior to synthetic dsRNA therapy enhanced the resultant anti-tumor activity |
| Q37875904 | Lymphatics: At the Interface of Immunity, Tolerance, and Tumor Metastasis |
| Q33509292 | Nanoparticle-delivered multimeric soluble CD40L DNA combined with Toll-Like Receptor agonists as a treatment for melanoma |
| Q34331993 | New roads open up for implementing immunotherapy in mesothelioma |
| Q40516283 | Poly (I:C) enhances the anti-tumor activity of canine parvovirus NS1 protein by inducing a potent anti-tumor immune response. |
| Q36068765 | Presensitizing with a Toll-like receptor 3 ligand impairs CD8 T-cell effector differentiation and IL-33 responsiveness |
| Q34400322 | TLR-based immune adjuvants. |
| Q37461812 | TLR3-stimulated dendritic cells up-regulate B7-H1 expression and influence the magnitude of CD8 T cell responses to tumor vaccination |
| Q37177519 | Targeting poly(I:C) to the TLR3-independent pathway boosts effector CD8 T cell differentiation through IFN-alpha/beta |
| Q33736218 | The "Trojan Horse" approach to tumor immunotherapy: targeting the tumor microenvironment |
| Q38026924 | The Use of Agonistic Anti-CD40 Therapy in Treatments for Cancer |
| Q36561226 | The effect of combined IL10 siRNA and CpG ODN as pathogen-mimicking microparticles on Th1/Th2 cytokine balance in dendritic cells and protective immunity against B cell lymphoma |
| Q35060384 | The efficacy of tumor debulking surgery is improved by adjuvant immunotherapy using imiquimod and anti-CD40 |
| Q35018021 | The pharmacokinetics of Toll-like receptor agonists and the impact on the immune system. |
| Q34210664 | Tumor antigen cross-presentation and the dendritic cell: where it all begins? |
| Q46217068 | Tumor eradication after cyclophosphamide depends on concurrent depletion of regulatory T cells: a role for cycling TNFR2-expressing effector-suppressor T cells in limiting effective chemotherapy |
| Q37792911 | Tumor-resident CD8+ T-cell: the critical catalyst in IL-12-mediated reversal of tumor immune suppression |
Search more.